Liverpool Facility Information:

cGMP manufacturing facility purpose-designed for viral vector manufacture

• Size: 103,000 ft²
• MHRA-licensed cGMP production suites
• Flexible state-of-the-art development and manufacturing
• Research grade, high quality, and plasmid DNA manufacturing
• Viral vector process development
• Product characterization and QC analytics
• GMP Gene Therapy Manufacturing and QP release

Watch our Liverpool Site Tour